...
机译:Tyrphostin RG14620选择性地逆转癌细胞系中ABCG2介导的多药抗性
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Laboratory of Cell Biology Center for Cancer Research National Cancer Institute NIH;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Graduate Institute of Biomedical Sciences College of Medicine Chang Gung University;
Graduate Institute of Biomedical Sciences China Medical University;
Laboratory of Cell Biology Center for Cancer Research National Cancer Institute NIH;
Department of Chemistry Tunghai University;
ABC transporter; ABCG2; EGFR inhibitor; Multidrug resistance; Tyrphostin RG14620;
机译:Tyrphostin RG14620选择性地逆转癌细胞系中ABCG2介导的多药抗性
机译:SIS3,SMAD3的特定抑制剂反转ABCB1和ABCG2介导的癌细胞系中的多药耐药性
机译:表皮生长因子受体(EGFR)抑制剂PD153035逆转非小细胞肺癌中的ABCG2介导的多药耐药性:体外和体内
机译:槲皮素对多药耐药癌细胞系中紫杉醇p-gp和COX-2表达及抗癌活性的影响
机译:海洋海绵衍生的七环素三萜类化合物逆转癌细胞中的P-糖蛋白(ABCB1)介导的多药耐药性
机译:Tyrphostin RG14620选择性逆转癌细胞系中ABCG2介导的多药耐药性
机译:AvaPritinib:一种选择性抑制剂和PDGFRα,可在癌细胞系中逆转ABCB1和ABCG2介导的多药耐药性